Easily accessible biomarkers are needed to diagnose cardiovascular disease precisely-particularly, to distinguish between disease subtypes that are encountered in clinical practice. Per the hypothesis that plasma miRNA is valuable for this purpose, we performed complete transcriptional profiling of an miRNA discovery-set in 14 samples: three patients with ST-elevanted acute myocardial infarction (STEMI) at baseline and after three months of follow-up, four with stable ischemic heart disease (stable-IHD), and four healthy age-matched volunteers. Our aim was to determine whether we could distinguish patients with unstable plaques from stable patients following a STEMI event. After analyzing miRNA profiles, we conducted a validation study comparing three-month STEMI (n = 40) with stable-IHD (n = 35), which confirmed that mir-486-3P differentiates patients with 3-month STEMI from those with stable IHD (P=0.019).
- Coronary Artery Disease
- Diagnosis biomarker
- ©2016 The Author(s)
This is an Accepted Manuscript; not the final Version of Record. You are encouraged to use the final Version of Record that, when published, will replace this manuscript and be freely available under a Creative Commons licence.